NAVIVA GROUP:

NAM HUNG VIET Vaccine & biological joint stock company

TUONG KHUE® Pharmaceutical joint stock company

WINBIO® Joint stock company

SUNMED Investment joint stock company

Total: 100131 Online: 0

Home > News

Gallery & Events

News

Career

20/05/2026

News

Scientific Symposium: VARICELLA – SECOND-GENERATION MAV/06 VACCINE AND UPDATES FROM THE WORLD HEALTH ORGANIZATION (WHO)

11/05/2026

News

WHY ARE VARICELLA-RELATED HOSPITALISATIONS STILL INCREASING DESPITE THE LONG AVAILABILITY OF VACCINES?

11/05/2026

News

WARNING OF RAPID VARICELLA TRANSMISSION AMONG YOUNG CHILDREN, EXPERTS RECOMMEND EARLY VACCINATION

11/05/2026

News

VARICELLA SHOULD NOT BE UNDERESTIMATED, PHYSICIANS WARN OF SERIOUS COMPLICATIONS

11/05/2026

News

VARICELLA IS NOT A “MILD” DISEASE AND CAN CAUSE SERIOUS COMPLICATIONS

18/03/2026

News

The MAV/06 strain varicella vaccine reinforces immunity in children with a prior history of varicella infection

13/02/2026

News

Naviva Group Organizes a Scientific Conference Series to Update on Advancements in Varicella Prevention Derived from the MAV/06 Strain

21/01/2026

News

NAVIVA Group Welcomes Students from Kelley School of Business, Indiana University (USA)

06/01/2026

News

MAV/06 Varicella Vaccine: Safety and Effectiveness for Global Immunization

24/12/2025

News

Antibiotic-Free Barycela Varicella Vaccine – An Optimal Safety Solution for Children

18/12/2025

News

Important improvements with the Barycela vaccine – The key to WHO-PQ

23/12/2025

News

Building Corporate Culture as a Foundation for Sustainable Development

16/12/2025

News

Barycela chickenpox vaccine – a suitable and reliable choice

29/12/2025

News

Naviva Group Hosts Scientific Conference on Advancements in Varicella Prevention Using the MAV/06 Strain in Ho Chi Minh City

24/09/2025

News

ANNOUNCEMENT ON CHANGE OF COMPANY HEADQUARTERS ADDRESS NAM HUNG VIET VACCINE & BIOLOGICAL PRODUCTS JOINT STOCK COMPANY

06/05/2026

News

VA-MENGOC BC Vaccine – An Effective Solution for the Prevention of Meningococcal Meningitis

16/04/2026

News

VARICELLA AND THE BARYCELA VACCINE FROM SOUTH KOREA

10/03/2026

News

VARICELLA AND THE BARYCELA VACCINE FOR DISEASE PREVENTION

10/03/2026

News

MAV/06 VARICELLA VACCINE AND ITS SAFE INTERCHANGEABILITY

29/12/2025

News

Naviva Group Hosts Scientific Conference on Advancements in Varicella Prevention Using the MAV/06 Strain in Da Nang City

26/12/2025

News

Effectiveness of the Barycela Vaccine and the Importance of the Second Dose

12/02/2026

News

SPREADING VALUE FROM TRAINING REFLECTIONS – “TO TRANSFORM THE MARKET, WE MUST FIRST TRANSFORM OURSELVES”

05/09/2025

News

The Power of Unity: Naviva Group Thrives at Team Building 2025

13/12/2025

News

News

Scientific Symposium: VARICELLA – SECOND-GENERATION MAV/06 VACCINE AND UPDATES FROM THE WORLD HEALTH ORGANIZATION (WHO)

WHY ARE VARICELLA-RELATED HOSPITALISATIONS STILL INCREASING DESPITE THE LONG AVAILABILITY OF VACCINES?

WARNING OF RAPID VARICELLA TRANSMISSION AMONG YOUNG CHILDREN, EXPERTS RECOMMEND EARLY VACCINATION

VARICELLA SHOULD NOT BE UNDERESTIMATED, PHYSICIANS WARN OF SERIOUS COMPLICATIONS

VARICELLA IS NOT A “MILD” DISEASE AND CAN CAUSE SERIOUS COMPLICATIONS

The MAV/06 strain varicella vaccine reinforces immunity in children with a prior history of varicella infection

Naviva Group Organizes a Scientific Conference Series to Update on Advancements in Varicella Prevention Derived from the MAV/06 Strain

NAVIVA Group Welcomes Students from Kelley School of Business, Indiana University (USA)

MAV/06 Varicella Vaccine: Safety and Effectiveness for Global Immunization

Antibiotic-Free Barycela Varicella Vaccine – An Optimal Safety Solution for Children

Important improvements with the Barycela vaccine – The key to WHO-PQ

Building Corporate Culture as a Foundation for Sustainable Development

Barycela chickenpox vaccine – a suitable and reliable choice

Naviva Group Hosts Scientific Conference on Advancements in Varicella Prevention Using the MAV/06 Strain in Ho Chi Minh City

ANNOUNCEMENT ON CHANGE OF COMPANY HEADQUARTERS ADDRESS NAM HUNG VIET VACCINE & BIOLOGICAL PRODUCTS JOINT STOCK COMPANY

VA-MENGOC BC Vaccine – An Effective Solution for the Prevention of Meningococcal Meningitis

VARICELLA AND THE BARYCELA VACCINE FROM SOUTH KOREA

VARICELLA AND THE BARYCELA VACCINE FOR DISEASE PREVENTION

MAV/06 VARICELLA VACCINE AND ITS SAFE INTERCHANGEABILITY

Naviva Group Hosts Scientific Conference on Advancements in Varicella Prevention Using the MAV/06 Strain in Da Nang City

Effectiveness of the Barycela Vaccine and the Importance of the Second Dose

SPREADING VALUE FROM TRAINING REFLECTIONS – “TO TRANSFORM THE MARKET, WE MUST FIRST TRANSFORM OURSELVES”

The Power of Unity: Naviva Group Thrives at Team Building 2025

WHO Releases New Guidelines on Varicella Vaccination

Community’s Health Is Our Happiness!